Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women

Journal of General Virology

Volumn 85, Issue 5, 2004, Pages 1237-1241

  Chaturvedi, Anil K ^a   Brinkman, Joeli A ^b   Gaffga, Ann M ^b   Dumestre, Jeanne ^b   Clark, Rebecca A ^b   Braly, Patricia S ^b   Dunlap, Kathleen ^b   Kissinger, Patricia J ^a   Hagensee, Michael E ^b  

^a TULANE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GUANINE; NUCLEOTIDE; PROTEIN E6;

ADULT; ARTICLE; ASIAN; CAUCASIAN; CELL LINEAGE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOLOGY; EUROPE; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LOGISTIC REGRESSION ANALYSIS; LYMPHOCYTE COUNT; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; VIRUS LOAD; WART VIRUS;

ADULT; AFRICAN AMERICANS; CERVIX UTERI; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; LOUISIANA; MUTATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; VAGINA; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 2442702739     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19694-0     Document Type: Article

References (39)

1. Ahdieh, L., Klein, R. S., Burk, R. & 7 other authors (2001). Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 184, 682-690.
2. Andersson, S., Alemi, M., Rylander, E., Strand, A., Larsson, B., Sallstrom, J. & Wilander, E. (2000). Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions. Br J Cancer 83, 307-310.
3. Berumen, J., Ordonez, R. M., Lazcano, E. & 7 other authors (2001). Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 93, 1325-1330.
4. Bosch, F. X., Manos, M. M., Munoz, N. & 7 other authors (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87, 796-802.
5. Castellsague, X., Bosch, F. X. & Munoz, N. (2002). Environmental co-factors in HPV carcinogenesis. Virus Res 89, 191-199.
6. Da Costa, M. M., Hogeboom, C. J., Holly, E. A. & Palefsky, J. M. (2002). Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. J Infect Dis 185, 1229-1237.
7. Ellis, J. R., Keating, P. J., Baird, J. & 7 other authors (1995). The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med 1, 464-470.
8. Giannoudis, A. & Herrington, C. S. (2001). Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 193, 295-302.
9. Gravitt, P. E., Peyton, C. L., Apple, R. J. & Wheeler, C. M. (1998). Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 36, 3020-3027.
10. Hildesheim, A. & Wang, S. S. (2002). Host and viral genetics and risk of cervical cancer: a review. Virus Res 89, 229-240.
11. Hildesheim, A., Herrero, R., Castle, P. E. & 13 other authors (2001a). HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 84, 1219-1226.
12. Hildesheim, A., Schiffman, M., Bromley, C. & 12 other authors (2001b). Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93, 315-318.
13. Icenogle, J. P., Laga, M., Miller, D., Manoka, A. T., Tucker, R. A. & Reeves, W. C. (1992). Genotypes and sequence variants of human papillomavirus DNAs from human immunodeficiency virus type 1-infected women with cervical intraepithelial neoplasia. J Infect Dis 166, 1210-1216.
14. Kammer, C., Tommasino, M., Syrjanen, S., Delius, H., Hebling, U., Warthorst, U., Pfister, H. & Zehbe, I. (2002). Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br J Cancer 86, 269-273.
15. Londesborough, P., Ho, L., Terry, G., Cuzick, J., Wheeler, C. & Singer, A. (1996). Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 69, 364-368.
16. Lorincz, A. T., Reid, R., Jenson, A. B., Greenberg, M. D., Lancaster, W. & Kurman, R. J. (1992). Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 79, 328-337.
17. Lorincz, A. T., Castle, P. E., Sherman, M. E. & 7 other authors (2002). Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360, 228-229.
18. Maciag, P. C. & Villa, L. L. (1999). Genetic susceptibility to HPV infection and cervical cancer. Braz J Med Biol Res 32, 915-922.
19. Mehta, C. R. & Patel, N. R. (1995). Exact logistic regression: theory and examples. Stat Med 14, 2143-2160.
20. Minkoff, H., Feldman, J., DeHovitz, J., Landesman, S. & Burk, R. (1998). A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol 178, 982-986.
21. Moreno, V., Munoz, N., Bosch, F. X. & 7 other authors (1995). Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer. Cancer Epidemiol Biomarkers Prev 4, 459-467.
22. Munoz, N., Bosch, F. X., de Sanjose, S. & 7 other authors (1992). The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 52, 743-749.
23. Munoz, N., Bosch, F. X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K. V., Snijders, P. J. & Meijer, C. J. (2003 . Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348, 518-527.
24. Palefsky, J. M., Minkoff, H., Kalish, L. A. & 7 other authors (1999). Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 91, 226-236.
25. Perez-Gallego, L., Moreno-Bueno, G., Sarrio, D., Suarez, A., Gamallo, C. & Palacios, J. (2001). Human papillomavirus-16 E6 variants in cervical squamous intraepithelial lesions from HIV-negative and HIV-positive women. Am J Clin Pathol 116, 143-148.
26. Stoppler, M. C., Ching, K., Stoppler, H., Clancy, K., Schlegel, R. & Icenogle, J. (1996). Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 70, 6987-6993.
27. Sun, X. W., Kuhn, L., Ellerbrock, T. V., Chiasson, M. A., Bush, T. J. & Wright, T. C., Jr (1997). Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 337, 1343-1349.
28. Ting, Y. & Manos, M. M. (1990). Detection and typing of genital human papillomaviruses. In PCR Protocols: a Guide to Methods and Applications, pp. 356-367. Edited by M. Innis, D. Gelfand, J. Sninsky & T. White. San Diego, CA: Academic Press.
29. van Belkum, A., Juffermans, L., Schrauwen, L., van Doornum, G., Burger, M. & Quint, W. (1995). Genotyping human papillomavirus type 16 isolates from persistently infected promiscuous individuals and cervical neoplasia patients. J Clin Microbiol 33, 2957-2962.
30. Vernon, S. D., Reeves, W. C., Clancy, K. A., Laga, M., St Louis, M., Gary, H. E., Jr, Ryder, R. W., Manoka, A. T. & Icenogle, J. P. (1994). A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women. J Infect Dis 169, 1108-1112.
31. Walboomers, J. M., Jacobs, M. V., Manos, M. M. & 7 other authors (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189, 12-19.
32. Welters, M. J., de Jong, A., van den Eeden, S. J. & 10 other authors (2003). Frequent display of human papillomavirus type 16 E6-specific memory T-helper cells in the healthy population as witness of previous viral encounter. Cancer Res 63, 636-641.
33. Xi, L. F., Koutsky, L. A., Galloway, D. A., Kuypers, J., Hughes, J. P., Wheeler, C. M., Holmes, K. K. & Kiviat, N. B. (1997). Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89, 796-802.
34. Xi, L. F., Critchlow, C. W., Wheeler, C. M. & 9 other authors (1998). Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res 58, 3839-3844.
35. Xi, L. F., Carter, J. J., Galloway, D. A. Kuypers J., Hughes, J. P., Lee, S. K., Adam, D.E., Kiviat, N. B. & Koutsky, L. A. (2002). Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev 11, 343-351.
36. Yamada, T., Wheeler, C. M., Halpern, A. L., Stewart, A. C., Hildesheim, A. & Jenison, S. A. (1995). Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 69, 7743-7753.
37. Yamada, T., Manos, M. M., Peto, J., Greer, C. E., Munoz, N., Bosch, F. X. & Wheeler, C. M. (1997). Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71, 2463-2472.
38. Zehbe, I., Wilander, E., Delius, H. & Tommasino, M. (1998). Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58, 829-833.
39. Zehbe, I., Voglino, G., Wilander, Delius, H., Marongiu, A., Edler, L., Klimek, F., Andersson, S. & Tommasino, M. (2001). p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res 61, 608-611.